Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes

Gustavo Saposnik1, David Gladstone, Roula Raptis

  • 1MSc, FAHA, FRCPC, Stroke Outcomes Research Center, Department of Medicine, St. Michael's Hospital, University of Toronto, 55 Queen St E, Toronto, Ontario, M5C 1R6, Canada. saposnikg@smh.ca

Stroke
|November 22, 2012
PubMed

Insights

Patients with atrial fibrillation (AF) face higher stroke mortality and hemorrhage risk. Thrombolysis showed no benefit for AF patients, unlike those without AF.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Atrial fibrillation (AF) is a significant risk factor for stroke.
  • AF is associated with poorer stroke outcomes and limited tools for evaluating treatment efficacy.
  • Assessing clinical outcomes in AF stroke patients receiving thrombolysis is crucial.

Purpose of the Study:

  • To evaluate the effectiveness of thrombolysis in acute ischemic stroke patients with and without atrial fibrillation.
  • To assess clinical outcomes, including favorable outcomes, intracerebral hemorrhage, and mortality, in stroke patients with AF.
  • To investigate the role of the iScore in predicting outcomes for stroke patients with AF.

Main Methods:

  • Applied the validated iScore risk assessment tool to acute ischemic stroke patients.
  • Analyzed data from the Registry of the Canadian Stroke Network.
  • Defined favorable outcome as modified Rankin scale 0-2 at discharge; secondary outcomes included intracerebral hemorrhage and mortality.

Main Results:

  • 17.2% of acute ischemic stroke patients had AF, exhibiting higher mortality and disability rates.
  • Thrombolysis improved outcomes in non-AF patients but showed no benefit in AF patients.
  • AF patients had a modestly increased risk of intracranial hemorrhage post-thrombolysis.

Conclusions:

  • Stroke patients with AF experience higher mortality and intracerebral hemorrhage risk.
  • Thrombolysis response in AF stroke patients is similar to non-AF patients, with no observed benefit.
  • The iScore interacts with tPA treatment for favorable outcomes, particularly in non-AF patients.
Abstract

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...